Néhémie Nzoyikorera1 , Cassien Nduwimana1 , Leonard Schuele2 , David F Nieuwenhuijse2 , Marion Koopmans2 , Saria Otani3 , Frank M Aarestrup3 , Théogène Ihorimbere1 , Denis Niyomwungere1 , Armstrong Ndihokubwayo1,4 , Idrissa Diawara5,6 , Alexis Niyomwungere7 , Dionis Nizigiyimana8 , Marie Noelle Uwimana1 , Bas B Oude Munnink2,* , Joseph Nyandwi8,9
We describe cases with monkeypox virus (MPXV) Clade Ib in Burundi from their first detection in July until 20 August 2024. Testing 442 people with vesicular lesions confirmed 170 cases (98 male; 72 female), 82 (48%) being < 15 years old. Differential diagnosis of the first 30 individuals testing MPXV negative revealed chickenpox in 20. Cases occurred in 26 of 49 Burundi health districts, but mostly in Bujumbura Nord (88/170; 67%). Case-derived MPXV genetic sequences from Burundi and South-Kivu (Democratic Republic of the Congo), clustered together in phylogenetic analysis.
We describe cases with monkeypox virus (MPXV) Clade Ib in Burundi from their first detection in July until 20 August 2024. Testing 442 people with vesicular lesions confirmed 170 cases (98 male; 72 female), 82 (48%) being < 15 years old. Differential diagnosis of the first 30 individuals testing MPXV negative revealed chickenpox in 20. Cases occurred in 26 of 49 Burundi health districts, but mostly in Bujumbura Nord (88/170; 67%). Case-derived MPXV genetic sequences from Burundi and South-Kivu (Democratic Republic of the Congo), clustered together in phylogenetic analysis.